Research Summary

Peanut allergy therapeutics refer to medical treatments and interventions developed to address peanut allergies, which are potentially life-threatening immune reactions to peanuts. These therapeutics aim to reduce the severity of allergic reactions or, in some cases, desensitize individuals with peanut allergies, allowing them to tolerate peanuts without experiencing severe symptoms. Immunotherapy, such as oral immunotherapy (OIT) and sublingual immunotherapy (SLIT), is a common approach, where individuals are gradually exposed to small, controlled amounts of peanut allergen to build tolerance. In some cases, biologics like monoclonal antibodies that target specific immune pathways involved in allergic responses are also being explored as treatment options. Peanut allergy therapeutics are critical for improving the quality of life and safety of individuals with peanut allergies by potentially reducing the risk of accidental exposure and severe allergic reactions.

According to DIResearch's in-depth investigation and research, the global Peanut Allergy Therapeutics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Peanut Allergy Therapeutics include Mylan, Bayer, UCB Pharma, Johnson & Johnson, Perrigo, GSK, Kaleo, Amneal Pharma, ALK Abello, Aimmune Therapeutics, HUAPONT Pharm, Sanofi, ASIT Biotech, Allergy Therapeutics, DBV Technologies, HAL Allergy, Intrommune Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Peanut Allergy Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Peanut Allergy Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peanut Allergy Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peanut Allergy Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Peanut Allergy Therapeutics Include:

Mylan

Bayer

UCB Pharma

Johnson & Johnson

Perrigo

GSK

Kaleo

Amneal Pharma

ALK Abello

Aimmune Therapeutics

HUAPONT Pharm

Sanofi

ASIT Biotech

Allergy Therapeutics

DBV Technologies

HAL Allergy

Intrommune Therapeutics

Peanut Allergy Therapeutics Product Segment Include:

Epinephrine Injection

Antihistamines

Oral Immunotherapy

Other

Peanut Allergy Therapeutics Product Application Include:

aeo??

o?<
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Peanut Allergy Therapeutics Industry PESTEL Analysis
Chapter 3: Global Peanut Allergy Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global Peanut Allergy Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Peanut Allergy Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Peanut Allergy Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Peanut Allergy Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources